Latest Reported Offering
$19,999
Target Amount
$1,234,998
Maximum Amount
2025-04-30
Deadline
Security Details
Type: Other
Price per share: $1.88
Price set by: N/A
Shares offered: 10,638+
Offering Costs
Cash commission: —
7 - 13 percent
Equity compensation: —
Three percent (3%) of securities of the total amount of investments raised in the offering, along the same terms as investors.
Filing history
Form C family — 5 filingsThe reported figures behind Diant Pharma Inc.
Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.
- Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
- A sparkline on each figure so the shape is visible before the numbers
- A revenue series dated to the filings that reported it
- The campaign as filed: target, ceiling, deadline, and the portal that ran it
- Follow it, and see it change on your watchlist
Company Information
Latest Metrics
Employees9
Total Assets$1,690,032
Cash on Hand$29,330
Revenues$1,530,991
Net Income-$538,167
Crowdfunding Portals
The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.